Inventor
MARCELA MAUS
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes8%
PatentTitleYear
12,559,562Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor202612,473,343Targeted t cells with cytotoxicity toward immunosuppressive cells202512,049,482Molecular switch-mediated control of engineered cells202411,865,167Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2025Patents assigned to MASSACHUSETTS GEN HOSPITAL (2)· patent assignee history
2024–2026Patents assigned to NOVARTIS AG (2)· patent assignee history
2024–2026Patents assigned to UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (2)· patent assignee history
2024–2026Patents assigned to UNIV PENNSYLVANIA (2)· patent assignee history
2024Patents assigned to BRIGHAM & WOMENS HOSPITAL INC (1)· patent assignee history
2024–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MASSACHUSETTS GEN HOSPITAL | 2 | 2024–2025 |
| NOVARTIS AG | 2 | 2024–2026 |
| UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2 | 2024–2026 |
| UNIV PENNSYLVANIA | 2 | 2024–2026 |
| BRIGHAM & WOMENS HOSPITAL INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2024–2026 |